Pacific Shuanglin Bio-pharmacy Co., LTD reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 435.64 million compared to CNY 260.86 million a year ago. Revenue was CNY 435.64 million compared to CNY 260.86 million a year ago.

Net income was CNY 121.95 million compared to CNY 56.38 million a year ago. Basic earnings per share from continuing operations was CNY 0.1669 compared to CNY 0.0771 a year ago. Diluted earnings per share from continuing operations was CNY 0.1669 compared to CNY 0.0771 a year ago.